8HRH
SN-131/1B2 anti-MUC1 antibody with a glycopeptide
Summary for 8HRH
Entry DOI | 10.2210/pdb8hrh/pdb |
Descriptor | Heavy chain of SN-131/1B2 antibody Fab, DI(HYDROXYETHYL)ETHER, GLYCEROL, ... (14 entities in total) |
Functional Keywords | antibody, immune system |
Biological source | Mus musculus More |
Total number of polymer chains | 2 |
Total formula weight | 80759.01 |
Authors | Wakui, H.,Horidome, C.,Yao, M.,Ose, T.,Nishimura, S.-I. (deposition date: 2022-12-15, release date: 2023-08-30) |
Primary citation | Wakui, H.,Yokoi, Y.,Horidome, C.,Ose, T.,Yao, M.,Tanaka, Y.,Hinou, H.,Nishimura, S.I. Structural and molecular insight into antibody recognition of dynamic neoepitopes in membrane tethered MUC1 of pancreatic cancer cells and secreted exosomes. Rsc Chem Biol, 4:564-572, 2023 Cited by PubMed Abstract: Pancreatic cancer is highly metastatic and has poor prognosis, mainly due to delayed detection, often after metastasis has occurred. A novel method to enable early detection and disease intervention is strongly needed. Here we unveil for the first time that pancreatic cancer cells (PANC-1) and secreted exosomes express MUC1 bearing cancer-relevant dynamic epitopes recognized specifically by an anti-MUC1 antibody (SN-131), which binds specifically core 1 but not core 2 type -glycans found in normal cells. Comprehensive assessment of the essential epitope for SN-131 indicates that PANC-1 cells produce dominantly MUC1 with aberrant -glycoforms such as Tn, T, and sialyl T (ST) antigens. Importantly, SN-131 showed the highest affinity with MUC1 bearing ST antigen at the immunodominant DTR motif ( = 1.58 nM) independent of the glycosylation states of other Ser/Thr residues in the MUC1 tandem repeats. The X-ray structure revealed that SN-131 interacts directly with Neu5Ac and root GalNAc of the ST antigen in addition to the proximal peptide region. Our results demonstrate that targeting -glycosylated "dynamic neoepitopes" found in the membrane-tethered MUC1 is a promising therapeutic strategy for improving the treatment outcome of patients with pancreatic cancer. PubMed: 37547453DOI: 10.1039/d3cb00036b PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (2.07 Å) |
Structure validation
Download full validation report